These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21174271)

  • 41. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome.
    Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A
    Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
    Kreutz RP; Stanek EJ; Aubert R; Yao J; Breall JA; Desta Z; Skaar TC; Teagarden JR; Frueh FW; Epstein RS; Flockhart DA
    Pharmacotherapy; 2010 Aug; 30(8):787-96. PubMed ID: 20653354
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm.
    Moayyedi P; Cranney A
    Am J Gastroenterol; 2008 Oct; 103(10):2428-31. PubMed ID: 18855852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Concomitant use of platelet aggregation inhibitors and proton pump inhibitors (PPIs): Position paper of the German Society for Digestive and Metabolic Diseases (DGVS) and the German Society of Cardiology (DGK).].
    Fischbach W; Darius H; Gross M; Koop H; Kruck I; Petersen KU
    Z Gastroenterol; 2010 Sep; 48(9):1156-63. PubMed ID: 20839167
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.
    Hulot JS; Collet JP; Silvain J; Pena A; Bellemain-Appaix A; Barthélémy O; Cayla G; Beygui F; Montalescot G
    J Am Coll Cardiol; 2010 Jul; 56(2):134-43. PubMed ID: 20620727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PPI co-therapy did not adversely affect outcomes in clopidogrel users.
    Leontiadis GI; Howden CW
    Aliment Pharmacol Ther; 2012 Jan; 35(2):313-4. PubMed ID: 22172084
    [No Abstract]   [Full Text] [Related]  

  • 47. Safety of concomitant use of proton pump inhibitors and clopidogrel.
    Khawaja O; Al-Mallah MH
    Am J Med; 2010 Apr; 123(4):e11; author reply e13. PubMed ID: 20362734
    [No Abstract]   [Full Text] [Related]  

  • 48. Combination therapy with clopidogrel and proton-pump inhibitors.
    Bhala N; Banerjee A
    Lancet; 2010 Jan; 375(9708):28; author reply 28-9. PubMed ID: 20109858
    [No Abstract]   [Full Text] [Related]  

  • 49. Peptic disease: a confounding factor for proton pump inhibitor-clopidogrel interaction?
    Alegre-del Rey EJ; Sierra-Sánchez J; Castaño-Lara R; Díaz-Alersi R
    Am J Cardiol; 2010 Jul; 106(2):294-5; author reply 295. PubMed ID: 20599021
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiovascular Risk of Proton Pump Inhibitors.
    Ariel H; Cooke JP
    Methodist Debakey Cardiovasc J; 2019; 15(3):214-219. PubMed ID: 31687101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The drug-drug interaction between proton pump inhibitors and clopidogrel.
    Lau WC; Gurbel PA
    CMAJ; 2009 Mar; 180(7):699-700. PubMed ID: 19332744
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comment of the Delphi Care editors on Critical evaluation of interaction screening software available in pharmacies].
    Duh D; Tanret I
    J Pharm Belg; 2012 Dec; (4):14-5. PubMed ID: 23350207
    [No Abstract]   [Full Text] [Related]  

  • 54. Conflicting evidence: what's a clinician to do?
    de Aquino Lima JP; Brophy JM
    Ann Intern Med; 2010 Sep; 153(6):413-5. PubMed ID: 20855806
    [No Abstract]   [Full Text] [Related]  

  • 55. Combination therapy with clopidogrel and proton-pump inhibitors.
    Muldowney JA; Benge CD
    Lancet; 2010 Jan; 375(9708):27-8; author reply 28-9. PubMed ID: 20109855
    [No Abstract]   [Full Text] [Related]  

  • 56. Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution.
    Friedman M; Maley A; Kelley K; Pulver T; Foster M; Fisher M; Joseph N
    Otolaryngol Head Neck Surg; 2011 Apr; 144(4):558-62. PubMed ID: 21493235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Gastroesophageal reflux disease: surgical or medical treatment? - Medical].
    Schepp W
    Dtsch Med Wochenschr; 2014 May; 139(17):892. PubMed ID: 24760692
    [No Abstract]   [Full Text] [Related]  

  • 58. Hoarseness and chronic cough: would you suspect reflux?
    Sana S; Sana M; Johnston N; Mittal SK
    J Fam Pract; 2011 Aug; 60(8):458-62. PubMed ID: 21814640
    [No Abstract]   [Full Text] [Related]  

  • 59. Opportunities to decrease inappropriate uses of proton pump inhibitors: Comment on "Proton pump inhibitor use and the antifracture efficacy of alendronate".
    Katz MH
    Arch Intern Med; 2011 Jun; 171(11):1004-5. PubMed ID: 21321289
    [No Abstract]   [Full Text] [Related]  

  • 60. Clopidogrel and proton pump inhibitors: can near patient testing help in the tailoring of dual antiplatelet prescription?
    Amoah V; Worrall AP; Smallwood A; Armesilla AL; Nevill AM; Cotton JM
    J Thromb Haemost; 2010 Jun; 8(6):1422-4. PubMed ID: 20345729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.